老百姓：老百姓2024年年度报告（英文版）.pdf

1、2024Annual Report of LBX Pharmacy Chain Joint Stock Company1/309Stock Code:603883Company Abbreviation:LBX2024 Annual ReportIn the event of any discrepancy between the Chinese and English versions,the Chinese version shallprevail.2024Annual Report of LBX Pharmacy Chain Joint Stock Company2/309Importa

2、nt NotesI.The Companys Board of Directors,Board of Supervisors,and directors,supervisors,seniorexecutives warrant the truthfulness,accuracy,and completeness of the content of this annualreport,confirm that there are no false records,misleading statements,or material omissions,andassume individual an

3、d joint legal liability.II.All directors of the Company attended the meeting of the Board of Directors.III.Ernst&Young Hua Ming LLPissued a standard unqualified auditor s report for theCompany.IV.The Companys principal Xie Zilong,person in charge of accounting work Chen Lishan,and person in charge o

4、f accounting department(chief accountant)Shi Lei declare:We warrantthe truthfulness,accuracy,and completeness of the financial report in this annual report.V.Profit distribution plan or plan for capitalization of capital reserves for the reporting periodapproved by the Board of Directors resolutionA

5、ccording to the proposal reviewed and approved at the 8th meeting of the 5th Board of Directorson April 29,2025,based on the total share capital on the record date for the implementation of theequity distribution,it is proposed to distribute a cash dividend of RMB 0.8(tax included)for every 10shares

6、 held by all shareholders.The Company will not issue bonus shares or convert capital reserves intoshare capital.As of March 31,2025,the Companys total share capital was 760,095,613 shares.Theproposed cash dividend distribution is RMB 60,807,649.04(tax included).The total proposed cashdividend for th